INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,785 | -96.9% | 2,460 | -96.1% | 0.00% | -94.7% |
Q2 2023 | $2,546,711 | +3441401.4% | 62,450 | +3054.0% | 0.02% | +1800.0% |
Q1 2023 | $74 | +8.8% | 1,980 | +1.0% | 0.00% | 0.0% |
Q4 2022 | $68 | -99.9% | 1,960 | -5.4% | 0.00% | 0.0% |
Q3 2022 | $109,000 | +38.0% | 2,072 | +36.3% | 0.00% | 0.0% |
Q2 2022 | $79,000 | -41.9% | 1,520 | -18.7% | 0.00% | 0.0% |
Q1 2022 | $136,000 | -53.4% | 1,870 | -39.5% | 0.00% | -50.0% |
Q4 2021 | $292,000 | -91.8% | 3,090 | -88.3% | 0.00% | -90.9% |
Q3 2021 | $3,554,000 | +619.4% | 26,491 | +768.6% | 0.02% | +633.3% |
Q2 2021 | $494,000 | +101.6% | 3,050 | 0.0% | 0.00% | +50.0% |
Q1 2021 | $245,000 | +47.6% | 3,050 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $166,000 | +295.2% | 3,050 | +45.2% | 0.00% | – |
Q3 2020 | $42,000 | -91.4% | 2,100 | -87.7% | 0.00% | -100.0% |
Q3 2018 | $489,000 | +123.3% | 17,100 | +113.8% | 0.00% | +100.0% |
Q2 2018 | $219,000 | +29.6% | 8,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $169,000 | +9.7% | 8,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $154,000 | -22.6% | 8,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $199,000 | +48.5% | 8,000 | +1.3% | 0.00% | 0.0% |
Q2 2017 | $134,000 | – | 7,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |